Georg Kralidis

698 total citations
13 papers, 536 citations indexed

About

Georg Kralidis is a scholar working on Surgery, Urology and Rheumatology. According to data from OpenAlex, Georg Kralidis has authored 13 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Urology and 4 papers in Rheumatology. Recurrent topics in Georg Kralidis's work include Pain Management and Opioid Use (3 papers), Pelvic floor disorders treatments (3 papers) and Urinary Bladder and Prostate Research (3 papers). Georg Kralidis is often cited by papers focused on Pain Management and Opioid Use (3 papers), Pelvic floor disorders treatments (3 papers) and Urinary Bladder and Prostate Research (3 papers). Georg Kralidis collaborates with scholars based in Switzerland, Germany and United Kingdom. Georg Kralidis's co-authors include Jenelle E. Foote, William D. Steers, Karin Glavind, Jacques Corcos, Jean‐Jacques Wyndaele, Peggy Norton, R. J. Millard, Christopher R. Chapple, Paul Abrams and Thomas M. Kessler and has published in prestigious journals such as The Journal of Urology, European Urology and American Journal of Transplantation.

In The Last Decade

Georg Kralidis

13 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georg Kralidis Switzerland 10 294 247 236 140 55 13 536
Björn Ekström Sweden 8 150 0.5× 83 0.3× 85 0.4× 42 0.3× 22 0.4× 21 271
Koji Ichihara Japan 10 200 0.7× 78 0.3× 74 0.3× 190 1.4× 11 0.2× 48 439
David Silvers United States 8 47 0.2× 19 0.1× 143 0.6× 144 1.0× 20 0.4× 13 374
Melanie M. van Riemsdijk Netherlands 10 138 0.5× 74 0.3× 39 0.2× 49 0.3× 18 0.3× 13 371
M. A. Pilot United Kingdom 11 14 0.0× 86 0.3× 30 0.1× 185 1.3× 24 0.4× 19 385
Steve Foley United Kingdom 6 121 0.4× 82 0.3× 75 0.3× 80 0.6× 6 0.1× 21 316
P Labay United States 11 181 0.6× 34 0.1× 32 0.1× 69 0.5× 7 0.1× 34 314
D Michel Switzerland 9 34 0.1× 33 0.1× 25 0.1× 56 0.4× 42 0.8× 21 348
Hitomi Sasaki Japan 11 37 0.1× 15 0.1× 24 0.1× 125 0.9× 10 0.2× 56 377

Countries citing papers authored by Georg Kralidis

Since Specialization
Citations

This map shows the geographic impact of Georg Kralidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Kralidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Kralidis more than expected).

Fields of papers citing papers by Georg Kralidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Kralidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Kralidis. The network helps show where Georg Kralidis may publish in the future.

Co-authorship network of co-authors of Georg Kralidis

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Kralidis. A scholar is included among the top collaborators of Georg Kralidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Kralidis. Georg Kralidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bushnell, Donald M., et al.. (2020). Pain assessment for chronic lower back pain: performance of the PAL-S and PAL-I patient-reported measures for symptoms and impacts. Current Medical Research and Opinion. 36(5). 853–863. 1 indexed citations
2.
Kralidis, Georg, et al.. (2019). Cebranopadol, a Novel First-in-Class Analgesic Drug Candidate: First Experience With Cancer-Related Pain for up to 26 Weeks. Journal of Pain and Symptom Management. 58(3). 390–399. 24 indexed citations
3.
Kennes, Lieven Nils, et al.. (2019). Study design aspects and inter‐subject variability in longitudinal clinical phase II dose‐finding trials. Pharmaceutical Statistics. 18(2). 248–259. 1 indexed citations
4.
Kralidis, Georg, et al.. (2018). Cancer‐related chronic pain: Investigation of the novel analgesic drug candidate cebranopadol in a randomized, double‐blind, noninferiority trial. European Journal of Pain. 23(3). 577–588. 32 indexed citations
5.
Kralidis, Georg, Thierry Carrel, Alexia Cusini, et al.. (2016). Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections. BMC Infectious Diseases. 16(1). 321–321. 12 indexed citations
6.
Manuel, Oriol, Georg Kralidis, Nicolas J. Mueller, et al.. (2013). Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant Recipients. American Journal of Transplantation. 13(9). 2402–2410. 80 indexed citations
7.
Kralidis, Georg, Katia Boggian, Alexia Cusini, et al.. (2013). Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss Transplant Cohort Study. Transplant Infectious Disease. 16(1). 26–36. 35 indexed citations
8.
Geusens, Piet, J Rovenský, Daniel B. Sloan, et al.. (2007). Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis: Results of a randomized double-blind study. Document Server@UHasselt (UHasselt). 1 indexed citations
9.
Chapple, Christopher R., William D. Steers, Peggy Norton, et al.. (2005). A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M 3 selective receptor antagonist, in the treatment of overactive bladder. British Journal of Urology. 95(7). 993–1001. 108 indexed citations
10.
Steers, William D., Jacques Corcos, Jenelle E. Foote, & Georg Kralidis. (2005). An investigation of dose titration with darifenacin, an M 3 ‐selective receptor antagonist. British Journal of Urology. 95(4). 580–586. 78 indexed citations
11.
Foote, Jenelle E., Karin Glavind, Georg Kralidis, & Jean‐Jacques Wyndaele. (2005). Treatment of Overactive Bladder in the Older Patient: Pooled Analysis of Three Phase III Studies of Darifenacin, an M3 Selective Receptor Antagonist. European Urology. 48(3). 471–477. 62 indexed citations
12.
Geusens, Piet, Rieke Alten, Jozef Rovenský, et al.. (2004). Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis. International Journal of Clinical Practice. 58(11). 1033–1041. 29 indexed citations
13.
Kessler, Thomas M., et al.. (2003). Long-term Results of Surgery For Urethral Stricture: A Statistical Analysis. The Journal of Urology. 170(3). 840–844. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026